The Financial Conflict of Interest Policy, Grants Information Memorandum (GIM) 10, establishes guidelines for disclosure of Significant Financial Interests and management of resulting Financial Conflicts of Interests in research, sponsored programs, and technology transfer activities at the University. The information accessible through this page provides details of relevant policies, procedures, and systems.
A Financial Conflict of Interest in research is present when a Significant Financial Interest affects, or could appear to affect, the professional judgment of a researcher when designing, conducting, or reporting research.
† Investigator status is determined by the Principal Investigator, FAQ.
An SFI exists when any of the following are received by an Investigator or their Immediate Family Member:
* Sponsored or reimbursed travel cost is a form of compensation when associated with a performed service.
New or increased SFI need to be disclosed:
State and Federal regulations require the University of Washington to have policies in place to promote objectivity in research, as well as to address State laws prohibiting state employees from having an interest that is in conflict with their official duties (RCW 42.52).
Using the Financial Interest Disclosure System (FIDS) – Overview and Navigation.
For collaborating institutions reporting FCOI (subrecipients of UW awards) or requesting updates regarding FCOIs identified in PHS-Sponsored Research at the University of Washington (prime awardees issuing subawards to UW) please contact us at fcoirep@uw.edu.
All subrecipients proposed must have their own FCOI compliant policy in place and make an assurance in the subaward to this regard. Reminders to the PI and eGC1 contacts regarding this requirement will be sent by OSP at JIT and award stage for projects or programs sponsored by an organization requiring Institutional Review of Investigator SFI.
For agencies or subrecipients that do not yet have their own policy, the National Institutes of Health (NIH) offer a Checklist for Policy Development.
I’m an Investigator participating in research where the sponsor requires Institutional Review and I received $5,000 in compensation for serving on the Scientific Advisory Board of a local biotechnology company within the past several months. I anticipate receiving an additional $2,000 for these services in the next few months of this total 12-month period—am I required to disclose this compensation?
Yes, compensation exceeding $5,000 received, or anticipated to be received, within a twelve (12) month period requires disclosure under GIM 10. (If only the original $5,000 in compensation were received, and no additional compensation was anticipated, then threshold for SFI would not be met and no disclosure would be required. Likewise, if greater than 12 months elapsed between receipt of the original $5,000 and the additional $2,000 and no other compensation was received or anticipated, no disclosure would be required).
I’m working with an Investigator Determined sponsor on research and I received $6,000 in compensation for serving on an Engineering Advisory Board for an Industrial Engineering firm—am I required to disclose this compensation?
If you advised on products or services you are evaluating in the course of your University research, or you determine the work you are doing on the Advisory Board is related to any of your University research, you must disclose this compensation and may be issued a Conflict Management Plan to mitigate any perceived or actual concerns that may arise under Washington State Ethics laws.
I am working with CoMotion to patent technology that I developed in my University laboratory. Do I need to disclose this as an Intellectual Property interest? What if I’m on the Board of Directors for a Company that wishes to license my technology?
No. Intellectual Property, and any associated royalties or payments that are managed by the University are considered to fall within your University responsibilities and compensation. However, disclosures of Significant Financial Interests in private companies should be submitted by IR-Investigators regardless of the entities’ interest in University technology. All Innovators with SFI in an entity licensing technology for which they are a contributor will be issued a Conflict Management Plan. CoMotion and the Office of Research work together closely at the time of negotiation of the IP agreement to support compliance with applicable policies.
I am receiving money from Industry, both for my University salary and for expenses to conduct research related to one of their products or services, should I disclose this as SFI?
No. Any sponsored-research managed by the University, that is—it was routed through an eGC1 and negotiated by the Office of Sponsored Programs—is considered to fall within the scope of your University responsibilities and compensation. If the entity sponsoring University research is also paying you directly for other services, that compensation may require disclosure as outlined by GIM 10.
I submitted and received approval for outside work via the Request for Approval of Outside Professional Work for Compensation (Form 1460) process, do I also need to report the compensation as a Significant Financial Interest in FIDS?
Yes, if the compensation meets thresholds defined in GIM 10 it may require disclosure in FIDS.